Venetoclax and azacitidine combination therapy (VEN+AZA) is a promising novel therapy for elderly or unfit patients with acute myeloid leukemia (AML). Recently, VEN+AZA with subsequent allo-hematopoie
Sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) remains a life-threatening complication after hematopoietic stem cell transplantation. In this retrospective study, defibrotide treatme
Objectives: To analyze the kinetics of T-cell subsets and thymic function reconstitution after allogeneic hematopoietic stem cell transplantation (AHSCT); to determine whether sjTREC (signal jo
